Loading your page…
Each register with its number of medicines and a few of them.
Anvisa · 1 medicine · Historical list
Health Canada · 1 medicine
AEMPS · 1 medicine
EMA · 1 medicine
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AIFA · 1 medicine
CBG-MEB · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
6 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| NEURACEQ 300 MBq/ml solucion inyectable | Spain | 300 MBq | solución inyectable | Marketed | Lantheus Germany Gmbh |
| Neuraceq | European Union | Authorised | Lantheus Germany GmbH | ||
| Neuraceq | Italy | Soluzione iniettabile | Authorised | Lantheus Germany GMBH | |
| Neuraceq 300 MBq/mL, oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Life Molecular Imaging GmbH | |
| Neuraceq | Canada | 5000 MBq / ML | Solution | Marketed | Isologic Innovative Radiopharmaceuticals LTD. |
| Neuraceq | Croatia | Authorised |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, EMA, HALMED and Health Canada. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
